UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloid-Derived Suppressor Cells

Cancer immunology research, 2017-01, Vol.5 (1), p.3-8

Gabrilovich, Dmitry I

2017

Volltextzugriff (PDF)

Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion

Stem cells (Dayton, Ohio), 2016-08, Vol.34 (8), p.2026-2039

2016

Volltextzugriff (PDF)

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

Frontiers in immunology, 2020-07, Vol.11, p.1680-1680

2020

Volltextzugriff (PDF)

Exosomes as mediators of immune regulation and immunotherapy in cancer

The FEBS journal, 2021-01, Vol.288 (1), p.10-35

2021

Volltextzugriff (PDF)

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Clinical cancer research, 2016-08, Vol.22 (15), p.3924-3936

2016

Volltextzugriff (PDF)

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Clinical cancer research, 2020-03, Vol.26 (6), p.1420-1431

2020

Volltextzugriff (PDF)

Effective combinatorial immunotherapy for castration-resistant prostate cancer

Nature (London), 2017-03, Vol.543 (7647), p.728-732

2017

Volltextzugriff (PDF)

Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives

Journal of cellular physiology, 2019-07, Vol.234 (7), p.9966-9981

2019

Volltextzugriff (PDF)

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (10), p.2607-2619

2017

Volltextzugriff (PDF)

Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis

Oncogene, 2017-02, Vol.36 (5), p.639-651

2017

Volltextzugriff (PDF)

Modulation of anti-tumor immunity by the brain's reward system

Nature communications, 2018-07, Vol.9 (1), p.2723-10, Article 2723

2018

Volltextzugriff (PDF)

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

British journal of haematology, 2020-11, Vol.191 (3), p.433-441

2020

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α

Clinical cancer research, 2017-05, Vol.23 (9), p.2346-2355

2017

Volltextzugriff (PDF)

The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors

The Prostate, 2019-10, Vol.79 (14), p.1611-1621

2019

Volltextzugriff (PDF)

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2477-2499

2020

Volltextzugriff (PDF)

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

Molecular therapy, 2021-01, Vol.29 (1), p.60-74

2021

Volltextzugriff (PDF)

Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma

Journal of investigative dermatology, 2017-08, Vol.137 (8), p.1740-1748

2017

Volltextzugriff (PDF)

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance

Frontiers in immunology, 2018-09, Vol.9, p.2134

2018

Volltextzugriff (PDF)

Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses

Clinical cancer research, 2021-01, Vol.27 (2), p.608-621

2021

Volltextzugriff (PDF)

Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

Journal of hepatology, 2019-03, Vol.70 (3), p.449-457

2019

Volltextzugriff (PDF)

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

Clinical cancer research, 2016-08, Vol.22 (15), p.3849-3859

2016

Volltextzugriff (PDF)

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity

Frontiers in immunology, 2020-08, Vol.11, p.1963-1963

2020

Volltextzugriff (PDF)

High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation

Nature communications, 2020-04, Vol.11 (1), p.1732-1732, Article 1732

2020

Volltextzugriff (PDF)

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Blood, 2017-03, Vol.129 (9), p.1166-1176

2017

Volltextzugriff (PDF)

Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

Clinical cancer research, 2017-06, Vol.23 (12), p.2942-2950

2017

Volltextzugriff (PDF)

1 – 25 von 504

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(453)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(485)
Life Sciences & Biomedicine
(450)
Animals
(388)
Humans
(323)
Mice
(304)
Myeloid-Derived Suppressor Cells - Drug Effects
(236)
Female
(211)
Myeloid-Derived Suppressor Cells - Immunology
(197)
Myeloid-Derived Suppressor Cells
(196)
Oncology
(179)
Immunology
(176)
Suppressor Cells
(147)
Cell Line, Tumor
(145)
Myeloid-Derived Suppressor Cells - Metabolism
(142)
Mice, Inbred C57bl
(139)
Male
(127)
Immunotherapy
(126)
Tumors
(116)
Cancer
(114)
Lymphocytes
(97)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myeloid-Derived Suppressor Cells

Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

Exosomes as mediators of immune regulation and immunotherapy in cancer

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Effective combinatorial immunotherapy for castration-resistant prostate cancer

Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ

Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis

Modulation of anti-tumor immunity by the brain's reward system

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α

The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice

Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance

Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses

Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity

High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

Suchergebnisse filtern